In this condition, the so-called “cholinic phenotype”, which is characterized by the overexpression of choline kinase alpha (CHKA) and increased phosphocholine (PCho) levels, supports aberrant lipid metabolic pathways typical of different cancers, including PCa. The gene discussed is CHKA; the disease is posterior cortical atrophy.